SAN DIEGO, Aug. 30, 2019 /PRNewswire/ -- Reneo Pharmaceuticals, a clinical stage pharmaceutical company, today announced that Alex Dorenbaum, MD, chief me

SAN DIEGO and VANCOUVER, British Columbia, Aug. 30, 2019 /PRNewswire/ -- Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological disease

SAN DIEGO and VANCOUVER, British Columbia, Aug. 30, 2019 /PRNewswire/ -- Sophiris Bio Inc. (Nasdaq: SPHS) (the "Company" or "Sophiris"), a biopharmaceutical company studying topsalysin (PRX302), a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases, today announce

CHICAGO, Aug. 30, 2019 /PRNewswire/ -- Preventing a patient from becoming malnourished can shorten his or her hospital stay, decrease hospital fees and, most importantly, improve the patient's quality of life. For those reasons, identifying and treating patients with malnutrition warrants the attention of health care providers and policymakers.

SIMSBURY, Conn., Aug. 30, 2019 /PRNewswire/ -- For years, Cathy Tolk found incomparable joy from giving back to the next generation. Whether it was visiting terminally ill children in hospitals around the country with her dog, Hollywood, or participating in the Meals on Wheels program, Cathy dedicated h

SIMSBURY, Conn., Aug. 30, 2019 /PRNewswire/ -- Tolk Chiropractic & Wellness Center is going beyond basic chiropractic care and offering companies the

SIMSBURY, Conn., Aug. 30, 2019 /PRNewswire/ -- Tolk Chiropractic & Wellness launches

DUBLIN, Aug. 30, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the Company and its U.S. subsidiaries have reached a settlement with plaintiffs scheduled for trial in October 2019 in the federal opioid multidistrict litigation. As part of the agreement, Allergan will pay $1.9 million to

CHARLOTTE, N.C., Aug. 30, 2019 /PRNewswire/ -- Nugenix®, an elite men's health supplement brand, was recently named GNC's "Top Product of the Year" for the second consecutive year (NYSE: GNC). Th

BALTIMORE, Aug. 30, 2019 /PRNewswire/ -- Prostate cancer is the second most common cancer for men, both in the United States and worldwide. In 2019, nearly 175,000 US men will be told they have prostate cancer – that is one new case every 3 minutes. Globally, the number increases to one new case every 41 seconds.E